Researchers Correct Atherosclerosis Study After Duplicate Panel Error

Researchers at the Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München (LMU), Munich, Germany, have corrected an error in their study published in the journal Nature on April 27, 2022. The correction involves the duplication of two panels in Extended Data Fig. 8, which was caused by a preparation error. This mistake does not affect the conclusions of the study, according to the researchers. The corrected figure is now available in both the HTML and PDF versions of the article. The study, which was conducted by a team of researchers led by Sarajo K. Mohanta, Li Peng, Christian Weber, Giuseppe Lembo, Daniela Carnevale, and Andreas J. R. Habenicht, explored the relationship between neuroimmune cardiovascular interfaces and atherosclerosis. Atherosclerosis is a condition characterized by the buildup of plaque in the arteries, which can lead to heart disease and stroke. According to the researchers, the study's findings suggest that neuroimmune cardiovascular interfaces play a crucial role in controlling atherosclerosis. The team used a combination of experimental and computational approaches to investigate the interactions between the nervous system and the cardiovascular system. Their results provide new insights into the mechanisms underlying atherosclerosis and may have implications for the development of new treatments for this condition. The researchers emphasized that the correction does not affect the validity of their findings. "The duplication of the panels was an error on our part, but it does not change the conclusions of the study," said Sarajo K. Mohanta, one of the lead authors. "We are confident that our results provide valuable insights into the relationship between neuroimmune cardiovascular interfaces and atherosclerosis." The study's findings have significant implications for our understanding of the complex interactions between the nervous system and the cardiovascular system. Atherosclerosis is a major public health concern, and new treatments are urgently needed to prevent and treat this condition. The researchers' work provides a new perspective on the role of neuroimmune cardiovascular interfaces in atherosclerosis and may lead to the development of new therapeutic strategies. The corrected study is now available online, and the researchers are continuing to investigate the mechanisms underlying atherosclerosis. Their work has the potential to improve our understanding of this complex condition and to lead to the development of new treatments for atherosclerosis and related cardiovascular diseases.